US2017145486A1PendingUtilityA1
Methods for variant detection
Est. expiryNov 25, 2035(~9.4 yrs left)· nominal 20-yr term from priority
Inventors:Caifu ChenJoseph DobosyPak Wah TsangMark Aaron BehlkeScott RoseKristin BeltzGarrett Richard Rettig
C12Q 1/6827C12Q 2535/125C12Q 2525/186C12Q 2525/185C12Q 2525/161C12Q 2525/155C12Q 2525/121C12Q 2521/327C12N 9/1252C12Y 207/07007C12Y 301/00G16B 30/00G16B 20/20C12Q 2600/156C07K 2319/21C12Q 1/6853C12N 9/22C12N 15/11C12Q 1/6858C12N 2310/20C12Y 301/26004C12Q 1/6876
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention can be used to provide a more efficient and less error-prone method of detecting variants in DNA, such as SNPs and indels. The invention also provides a method for performing inexpensive multiplex assays.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 : A method of detecting a variation in a target DNA sequence, the method comprising:
(a) providing a reaction mixture comprising:
(i) an oligonucleotide primer having a cleavage domain positioned 5′ of a blocking group and 3′ of a position of variation, the blocking group linked at or near the end of the 3′-end of the oligonucleotide primer wherein the blocking group prevents primer extension and/or inhibits the primer from serving as a template for DNA synthesis,
(ii) a sample nucleic acid that may or may not have the target sequence, and where the target sequence may or may not have the variation,
(iii) a cleaving enzyme, and
(iv) a polymerase;
(b) hybridizing the primer to the target DNA sequence to form a double-stranded substrate; (c) cleaving the hybridized primer, if the primer is complementary at the variation, with the cleaving enzyme at a point within or adjacent to the cleavage domain to remove the blocking group from the primer; and (d) extending the primer with the polymerase.
11 : The method of claim 10 , wherein the cleaving enzyme is a hot start cleaving enzyme that is thermostable and has reduced activity at lower temperatures.
12 : The method of claim 10 , wherein the cleaving enzyme is a chemically modified hot start cleaving enzyme that is thermostable and has reduced activity at lower temperatures.
13 : The method of claim 12 , wherein the hot start cleaving enzyme is a chemically modified Pyrococcus abyssi RNase H2.
14 : The method of claim 10 , wherein the cleaving enzyme is a hot start cleaving enzyme that is reversibly inactivated through interaction with an antibody at lower temperatures.
15 : The method of claim 10 , wherein the cleaving domain is comprised of at least one RNA base, and the cleaving enzyme cleaves between the position complementary to the variation and the RNA base.
16 : The method of claim 10 , wherein the cleaving domain is comprised of one or more 2′-modified nucleosides, and the cleaving enzyme cleaves between the position complementary to the variation and the one or more modified nucleosides.
17 : The method of claim 16 , wherein the one or more modified nucleosides are 2′-fluoronucleosides.
18 : The method of claim 10 , wherein the polymerase is a high-discrimination polymerase.
19 : The method of claim 10 , wherein the polymerase is a mutant H784Q Taq polymerase.
20 : The method of claim 19 , wherein the mutant H784Q Taq polymerase is reversibly inactivated via chemical, aptamer, or antibody modification.
21 : The method of claim 10 , wherein the primer contains a 5′ tail sequence that comprises a universal primer sequence and optionally a universal probe sequence, wherein the tail is non-complementary to the target DNA sequence.
22 - 53 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.